Investigator-assessed survival from end of treatment according to PET CR status assessed by standard Lugano 2014 response criteria (PET ITT population). (A) PFS (n = 1092). (B) OS (n = 1145). Final data cutoff, 31 January 2018. According to standard Lugano 2014 response criteria, no PET CR includes PR, nonresponse, and progressive disease patients with no progressive disease event by primary end point definition (investigator-assessed PFS). P values by log-rank test.